PTPN22 and neoplasm: Collectively, these results show that lack of PTPN22 in CTL enhances effector function in response to antigen, but if administered to tumor bearing hosts in numbers insufficient to rapidly control tumor growth, Ptpn22KO CTL are more prone to exhaustion and fail to give prolonged protection against tumors.